Hamim Zahir

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Topics

Direct Oral Anticoagulants

Drug Administration

Top Venues

Clinical pharmacology and therapeutics

British journal of clinical pharmacology

CPT: pharmacometrics & systems pharmacology

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Xavier J H Pepin, Scott M Hynes, Hamim Zahir, Deborah Walker, Lois Q Semmens, Sandra Suarez-Sharp
Understanding the mechanisms of food effect on omaveloxolone pharmacokinetics through physiologically based biopharmaceutics modeling. CPT: pharmacometrics & systems pharmacology (2024)
Peng Zou, Hamim Zahir, Anil Duggal, Grishma Pandya, James Jin, Tarek A Leil
Pharmacokinetics, Pharmacodynamics, and Safety of Edoxaban in Pediatric Subjects: A Phase I Single-Dose Study. Clinical pharmacology and therapeutics (2024)
Peng Zou, Hamim Zahir, Anil Duggal, Grishma Pandya, James Jin, Tarek A Leil
Pharmacokinetics, Pharmacodynamics, and Safety of Edoxaban in Pediatric Subjects: A Phase I Single-Dose Study. Clinical pharmacology and therapeutics 116 (3) (2024)
Jeanne Mendell, Naama Levy-Cooperman, Ed Sellers, Bradley Vince, Debra Kelsh, James Lee, Vance Warren, Hamim Zahir
Abuse potential of mirogabalin in recreational polydrug users. Therapeutic advances in drug safety 10 (2019)
Karen Brown, Jeanne Mendell, Shoichi Ohwada, Ching Hsu, Ling He, Vance Warren, Victor Dishy, Hamim Zahir
Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 studies. Pharmacology research & perspectives 6 (5) (2018)
Masaya Tachibana, Naotoshi Yamamura, George J Atiee, Ching Hsu, Vance Warren, Ling He, Victor Dishy, Hamim Zahir
Coadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open-label, drug-drug interaction study. British journal of clinical pharmacology 84 (10) (2018)
Kenneth Duchin, Giorgio Senaldi, Vance Warren, Thomas Marbury, Kenneth Lasseter, Hamim Zahir
Open-Label Single-Dose Study to Assess the Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics of Mirogabalin. Clinical drug investigation 38 (11) (2018)
Masaya Tachibana, Kyriakos P Papadopoulos, John H Strickler, Igor Puzanov, Roohi Gajee, Yibin Wang, Hamim Zahir
Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours. British journal of clinical pharmacology 84 (1) (2017)